Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
ONYX PHARMACEUTICALS INC (ONXX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2013 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 10/11/2013 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 10/03/2013 |
4
| CAGNONI PABLO J (EVP, Global R&D and Tech Ops) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Disposed/sold 16,257 shares
@ $125, valued at
$2M
Disposed/sold 34,030 options
@ $87.83, valued at
$3M
|
|
| 10/03/2013 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 9,080 shares
@ $125, valued at
$1.1M
Disposed/sold 2,100 shares
@ $125, valued at
$262.5k
Disposed/sold 10,000 options
@ $32.93, valued at
$329.3k
Disposed/sold 10,000 options
@ $29.39, valued at
$293.9k
Disposed/sold 5,000 options
@ $11.86, valued at
$59.3k
Disposed/sold 10,000 options
@ $55.06, valued at
$550.6k
Disposed/sold 10,000 options
@ $29.7, valued at
$297k
Disposed/sold 1,452 options
@ $28.55, valued at
$41.5k
Disposed/sold 5,000 options
@ $30.28, valued at
$151.4k
Disposed/sold 5,000 options
@ $35.18, valued at
$175.9k
Disposed/sold 5,000 options
@ $37.68, valued at
$188.4k
|
|
| 10/03/2013 |
4
| SHEMA SUZANNE M (EVP,GC and Corp. Secretary) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 6,468 shares
@ $125, valued at
$808.5k
Disposed/sold 28,150 shares
@ $125, valued at
$3.5M
Disposed/sold 12,472 options
@ $32.07, valued at
$400k
Disposed/sold 1,214 options
@ $32.07, valued at
$38.9k
Disposed/sold 1,969 options
@ $30.28, valued at
$59.6k
Disposed/sold 3,281 options
@ $30.28, valued at
$99.3k
Disposed/sold 3,553 options
@ $35.18, valued at
$125k
Disposed/sold 12,489 options
@ $35.18, valued at
$439.4k
Disposed/sold 2,157 options
@ $37.68, valued at
$81.3k
Disposed/sold 16,510 options
@ $37.68, valued at
$622.1k
Disposed/sold 903 options
@ $37.68, valued at
$34k
|
|
| 10/03/2013 |
4
| WOOD JULIANNA R (VP, Public Affairs) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 9,824 shares
@ $125, valued at
$1.2M
Unknown transaction of 200 shares
@ $125, valued at
$25k
Disposed/sold 9,550 shares
@ $125, valued at
$1.2M
Disposed/sold 2,555 options
@ $30.28, valued at
$77.4k
Disposed/sold 2,549 options
@ $30.28, valued at
$77.2k
Disposed/sold 2,618 options
@ $35.18, valued at
$92.1k
Disposed/sold 5,403 options
@ $35.18, valued at
$190.1k
Disposed/sold 3,069 options
@ $37.68, valued at
$115.6k
Disposed/sold 13,222 options
@ $37.68, valued at
$498.2k
Disposed/sold 7,000 options
@ $88.86, valued at
$622k
|
|
| 10/03/2013 |
4
| Fust Matthew K (EVP & CFO) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 9,153 shares
@ $125, valued at
$1.1M
Disposed/sold 31,150 shares
@ $125, valued at
$3.9M
Disposed/sold 41,450 options
@ $34.48, valued at
$1.4M
Disposed/sold 3,904 options
@ $30.28, valued at
$118.2k
Disposed/sold 41,596 options
@ $30.28, valued at
$1.3M
Disposed/sold 3,019 options
@ $35.18, valued at
$106.2k
Disposed/sold 38,981 options
@ $35.18, valued at
$1.4M
Disposed/sold 2,856 options
@ $37.68, valued at
$107.6k
Disposed/sold 43,044 options
@ $37.68, valued at
$1.6M
Disposed/sold 22,600 options
@ $88.86, valued at
$2M
|
|
| 10/03/2013 |
4
| Foster-Cheek Kaye I (SVP, Global Human Resources) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 5,666 shares
@ $125, valued at
$708.3k
Disposed/sold 21,400 shares
@ $125, valued at
$2.7M
Disposed/sold 11,660 options
@ $26.38, valued at
$307.6k
Disposed/sold 21,172 options
@ $26.38, valued at
$558.5k
Disposed/sold 1,750 options
@ $35.18, valued at
$61.6k
Disposed/sold 9,917 options
@ $35.18, valued at
$348.9k
Disposed/sold 3,407 options
@ $37.68, valued at
$128.4k
Disposed/sold 22,059 options
@ $37.68, valued at
$831.2k
Disposed/sold 15,100 options
@ $88.86, valued at
$1.3M
|
|
| 10/03/2013 |
4
| COLES N ANTHONY (Chairman & CEO) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 25,632 shares
@ $125, valued at
$3.2M
Disposed/sold 105,566 shares
@ $125, valued at
$13.2M
Disposed/sold 5,247 options
@ $28.55, valued at
$149.8k
Disposed/sold 3,302 options
@ $30.28, valued at
$100k
Disposed/sold 143,698 options
@ $30.28, valued at
$4.4M
Disposed/sold 2,842 options
@ $35.18, valued at
$100k
Disposed/sold 45,283 options
@ $35.18, valued at
$1.6M
Disposed/sold 2,653 options
@ $37.68, valued at
$100k
Disposed/sold 139,947 options
@ $37.68, valued at
$5.3M
Disposed/sold 75,300 options
@ $88.86, valued at
$6.7M
|
|
| 10/03/2013 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 7,737 shares
@ $125, valued at
$967.1k
Disposed/sold 2,100 shares
@ $125, valued at
$262.5k
Disposed/sold 5,417 options
@ $36.61, valued at
$198.3k
Disposed/sold 5,000 options
@ $37.68, valued at
$188.4k
Disposed/sold 2,000 options
@ $76.79, valued at
$153.6k
Disposed/sold 5,900 options
@ $88.86, valued at
$524.3k
|
|
| 10/03/2013 |
4
| GRILLO LOPEZ ANTONIO J (Director) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Disposed/sold 2,100 shares
@ $125, valued at
$262.5k
Disposed/sold 5,900 options
@ $88.86, valued at
$524.3k
|
|
| 10/03/2013 |
4
| LUNDBERG MAGNUS (Director) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 12,116 shares
@ $125, valued at
$1.5M
Disposed/sold 2,100 shares
@ $125, valued at
$262.5k
Disposed/sold 10,000 options
@ $31.7, valued at
$317k
Disposed/sold 10,000 options
@ $33.7, valued at
$337k
Disposed/sold 4,041 options
@ $28.55, valued at
$115.4k
Disposed/sold 5,000 options
@ $30.28, valued at
$151.4k
Disposed/sold 5,000 options
@ $35.18, valued at
$175.9k
Disposed/sold 5,000 options
@ $37.68, valued at
$188.4k
Disposed/sold 2,000 options
@ $76.79, valued at
$153.6k
Disposed/sold 5,900 options
@ $88.86, valued at
$524.3k
|
|
| 10/03/2013 |
4
| Torley Helen (EVP, Chief Commercial Officer) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 7,336 shares
@ $125, valued at
$917k
Disposed/sold 28,575 shares
@ $125, valued at
$3.6M
Disposed/sold 11,868 options
@ $33.7, valued at
$400k
Disposed/sold 44,132 options
@ $33.7, valued at
$1.5M
Disposed/sold 1,144 options
@ $37.68, valued at
$43.1k
Disposed/sold 12,156 options
@ $37.68, valued at
$458k
Disposed/sold 24,300 options
@ $88.86, valued at
$2.2M
|
|
| 10/03/2013 |
4
| Nevinny Corinne H (Director) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Disposed/sold 2,100 shares
@ $125, valued at
$262.5k
Disposed/sold 20,000 options
@ $24.14, valued at
$482.8k
Disposed/sold 10,000 options
@ $44.12, valued at
$441.2k
Disposed/sold 10,000 options
@ $31.04, valued at
$310.4k
Disposed/sold 2,410 options
@ $28.55, valued at
$68.8k
Disposed/sold 5,000 options
@ $30.28, valued at
$151.4k
Disposed/sold 5,000 options
@ $35.18, valued at
$175.9k
Disposed/sold 5,000 options
@ $37.68, valued at
$188.4k
Disposed/sold 2,000 options
@ $76.79, valued at
$153.6k
Disposed/sold 5,900 options
@ $88.86, valued at
$524.3k
|
|
| 10/03/2013 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 6,015 shares
@ $125, valued at
$751.9k
Disposed/sold 2,100 shares
@ $125, valued at
$262.5k
Disposed/sold 6,000 options
@ $27.63, valued at
$165.8k
Disposed/sold 10,000 options
@ $25.67, valued at
$256.7k
Disposed/sold 10,000 options
@ $25.05, valued at
$250.5k
Disposed/sold 5,287 options
@ $28.55, valued at
$150.9k
Disposed/sold 5,000 options
@ $30.28, valued at
$151.4k
Disposed/sold 5,000 options
@ $35.18, valued at
$175.9k
Disposed/sold 5,000 options
@ $37.68, valued at
$188.4k
Disposed/sold 2,000 options
@ $76.79, valued at
$153.6k
Disposed/sold 5,900 options
@ $88.86, valued at
$524.3k
|
|
| 10/03/2013 |
4
| Lasowski Juergen (EVP, Corp. Dev & Strategy) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 1,833 shares
@ $125, valued at
$229.1k
Disposed/sold 30,250 shares
@ $125, valued at
$3.8M
Disposed/sold 11,212 options
@ $35.67, valued at
$399.9k
Disposed/sold 72,788 options
@ $35.67, valued at
$2.6M
Disposed/sold 2,625 options
@ $28.55, valued at
$74.9k
Disposed/sold 3,452 options
@ $30.28, valued at
$104.5k
Disposed/sold 38,548 options
@ $30.28, valued at
$1.2M
Disposed/sold 2,500 options
@ $35.18, valued at
$88k
Disposed/sold 37,500 options
@ $35.18, valued at
$1.3M
Disposed/sold 925 options
@ $35.18, valued at
$32.5k
Disposed/sold 37,575 options
@ $35.18, valued at
$1.3M
|
|
| 10/03/2013 |
4
| GODDARD PAUL (Director) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 12,790 shares
@ $125, valued at
$1.6M
Disposed/sold 2,100 shares
@ $125, valued at
$262.5k
Disposed/sold 1,000 options
@ $28.41, valued at
$28.4k
Disposed/sold 10,000 options
@ $26.69, valued at
$266.9k
Disposed/sold 10,000 options
@ $45.09, valued at
$450.9k
Disposed/sold 5,726 options
@ $28.55, valued at
$163.5k
Disposed/sold 5,000 options
@ $30.28, valued at
$151.4k
Disposed/sold 5,000 options
@ $35.18, valued at
$175.9k
Disposed/sold 5,000 options
@ $37.68, valued at
$188.4k
Disposed/sold 2,000 options
@ $76.79, valued at
$153.6k
Disposed/sold 5,900 options
@ $88.86, valued at
$524.3k
|
|
| 10/02/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 10/02/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/01/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
|
|
|